These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21302589)

  • 1. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?
    Dooley K; Sullivan JA
    Health Care Law Mon; 2010 Oct; 2010(10):2-8. PubMed ID: 21302589
    [No Abstract]   [Full Text] [Related]  

  • 2. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 5. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy implications of drug importation.
    Palumbo FB; Mullins CD; Slagle AF; Rizer J
    Clin Ther; 2007 Dec; 29(12):2758-67. PubMed ID: 18201594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 8. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 9. Market watch: Specialty pharmaceuticals to provide majority of sales by 2012.
    Goodman M
    Nat Rev Drug Discov; 2009 Mar; 8(3):184. PubMed ID: 19247297
    [No Abstract]   [Full Text] [Related]  

  • 10. Trojan drugs: counterfeit and mislabeled pharmaceuticals in the legitimate market.
    deKieffer D
    Am J Law Med; 2006; 32(2-3):325-49. PubMed ID: 16927614
    [No Abstract]   [Full Text] [Related]  

  • 11. [Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
    Tamir O; Friedman N; Furman-Assaf S; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):466-9, 479. PubMed ID: 21465763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A perspective on US drug reimportation.
    Choudhry NK; Detsky AS
    JAMA; 2005 Jan; 293(3):358-62. PubMed ID: 15657329
    [No Abstract]   [Full Text] [Related]  

  • 13. Combating counterfeit drugs.
    Land T
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731208
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
    Hunnisett-Dritz D
    Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113
    [No Abstract]   [Full Text] [Related]  

  • 15. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 16. Rx: Canadian drugs.
    Rawson NS
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15017685
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 18. An uncertain future for cardiovascular drug development?
    Garber AM
    N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568
    [No Abstract]   [Full Text] [Related]  

  • 19. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.